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C
ivil society organizations (CSOs) 
are nonproﬁ  t organizations that 
aim to further the interests of 
the communities they serve. Driven to 
protect and empower the vulnerable, 
CSOs work in areas such as community 
development, service provision, 
advocacy, activism, and research. 
Sanders and colleagues argue that 
CSOs are at the forefront of supporting 
innovations aimed at tackling today’s 
global public health challenges and 
that working with them plays a crucial 
role in making research relevant 
to communities [1]. While several 
publications have addressed the role 
of CSOs in social science research in 
health [2–4], their role in biomedical 
research has not been widely discussed. 
The recent termination of tenofovir-
based HIV prevention trials in 
Cambodia, Cameroon, and Nigeria, 
primarily as a result of pressure from 
CSOs, underscores the signiﬁ  cant 
impact CSOs can have on biomedical 
research [5]. In Cambodia, in 
particular, intense pressure from 
CSOs inﬂ  uenced the Prime Minister’s 
decision to suspend a trial of tenofovir 
(an antiretroviral medication used 
to treat HIV) among commercial 
sex workers [5]. Similar outcomes 
have occurred in other countries 
hosting tenofovir prevention studies, 
and have complicated potentially 
promising research on this drug [6,7]. 
The termination of these trials has 
reinforced the importance of engaging 
with communities and CSOs, and being 
sensitive to their respective needs and 
perceptions. 
In October 2005 the Bill & Melinda 
Gates Foundation announced an 
approximately US$450 million 
sponsorship of 44 innovative projects 
under the auspices of its Grand 
Challenges in Global Health (GCGH) 
initiative. As described in the opening 
article in this series, we serve as an 
advisory service on ethical, social, 
and cultural (ESC) issues for these 
projects [8]. We are exploring a range 
of ESC issues identiﬁ  ed by the GCGH 
investigators and independently by 
developing world key informants in a 
study published as the second paper 
in this series [9]. The investigators 
and key informants placed particular 
emphasis on the importance of 
engaging with CSOs in research, and 
therefore we prepared a conceptual 
paper on this topic, which we 
distributed as a working paper to 
GCGH investigators and program staff 
at the 2nd Annual GCGH Meeting held 
in Washington, D. C. in October 2006. 
This work represents the ﬁ  nal version 
of our analysis. Our article aims to 
delineate different types of CSOs, their 
role in biomedical research, and the 
advantages and challenges of working 
with them. We stress that despite the 
challenges, it is in the best interests 
of science and researchers working 
in the developing world to identify 
and engage with CSOs. We also argue 
that there is a need for empirical 
research on best practice models of 
CSO–researcher engagements and for 
evaluation of these models.
CSOs in the Developing World
CSOs are common in the developing 
world. In Bangladesh, for example, one 
study found at least one CSO in over 
90% of villages surveyed in 2000 [10]. 
The Bangladesh Rural Advancement 
Committee (http: ⁄⁄www.brac.net/), 
which is involved in health services 
provision throughout the country, has 
in recent years founded a university, 
including a public health school to 
train public health researchers and 
practitioners. CSOs can be divided into 
ﬁ  ve types:
Nongovernmental organizations. 
Nongovernmental organizations 
(NGOs) work outside the direct 
control of governments. They can be 
as large as Médecins Sans Frontières 
or Greenpeace, or small and located 
in a single developing country village. 
Grand Challenges in Global Health: 
Engaging Civil Society Organizations in 
Biomedical Research in Developing Countries
Anant Bhan*, Jerome A. Singh, Ross E. G. Upshur, Peter A. Singer, Abdallah S. Daar
The Policy Forum allows health policy makers around 
the world to discuss challenges and opportunities for 
improving health care in their societies.
Citation: Bhan A, Singh JA, Upshur REG, Singer PA, 
Daar AS (2007) Grand Challenges in Global Health: 
Engaging civil society organizations in biomedical 
research in developing countries. PLoS Med 4(9): 
e272. doi:10.1371/journal.pmed.0040272 
Copyright: © 2007 Bhan et al. This is an open-access 
article distributed under the terms of the Creative 
Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in 
any medium, provided the original author and source 
are credited.
Abbreviations: CSO, civil society organization; 
ESC, ethical, social, and cultural; GCGH, Grand 
Challenges in Global Health; NGO, nongovernmental 
organization
The Ethical, Social and Cultural Program of the Grand 
Challenges in Global Health initiative is based at 
the Program on Life Sciences, Ethics, and Policy at 
the McLaughlin-Rotman Centre for Global Health, 
University Health Network/McLaughlin Centre for 
Molecular Medicine, University of Toronto, Toronto, 
Ontario, Canada. Anant Bhan is an independent 
researcher in Pune, India and bioethicist in the 
Ethical, Social and Cultural Program for the Grand 
Challenges in Global Health Initiative. Jerome A. 
Singh is at the Department of Public Health Sciences, 
and the Joint Centre for Bioethics at the University of 
Toronto, Toronto, Ontario, Canada; the Centre for the 
AIDS Programme of Research in South Africa, Durban, 
South Africa; and the Howard College School of Law, 
University of KwaZulu-Natal, Durban, KwaZulu-Natal, 
South Africa. Ross E. G. Upshur is at the Joint Centre 
for Bioethics, and the Departments of Family and 
Community Medicine and Public Health Sciences at 
the University of Toronto, Toronto, Ontario, Canada. 
Peter A. Singer is at the McLaughlin-Rotman Centre 
for Global Health and the Department of Medicine at 
the University of Toronto, Toronto, Ontario, Canada. 
Abdallah S. Daar is at the McLaughlin-Rotman Centre 
for Global Health and the Department of Public 
Health Sciences and Massey College at the University 
of Toronto, Toronto, Ontario, Canada.
* To whom correspondence should be addressed: 
anant.bhan@utoronto.caPLoS Medicine  |  www.plosmedicine.org 1457 September 2007  |  Volume 4  |  Issue 9  |  e272
The World Bank describes NGOs as 
“private organizations that pursue 
activities to relieve suffering, promote 
the interests of the poor, protect the 
environment, provide basic social 
services, or undertake community 
development” [11]. NGO activities 




draw their membership from the 
communities they serve. While most 
have leaders, decisions are typically 
collective in nature. Self-help groups 
of women in a village involved in 
microﬁ  nance initiatives are an example 
of such a body.
Faith-based organizations. Faith-
based organizations draw the purpose 
of their work from a particular faith 
or religious belief and may work 
through local centers of faith, such 
as churches, mosques, or temples. 
Examples include the Salvation Army, 
the YMCA, and the Ramakrishna 
Mission. Collaborating with such bodies 
would be especially useful in countries 
that are home to distinct religious 
groups. A recent United Nations study 
acknowledged the important role faith-
based organizations play in responding 
to HIV/AIDS, especially in sub-
Saharan Africa, and called for “greater 
collaboration between them and public 
health agencies” [13]. 
Voluntary health organizations. 
Voluntary health organizations are 
patient advocacy organizations, 
often focused on a single disease or 
syndrome, that promote research and 
participation in trials, treatment access, 
and aid for those affected by disease. 
They regularly discuss health issues 
with policy makers and the public. 
Examples include the Global Network 
for People Living with HIV/AIDS, the 
Eye Bank Association of India, and 
Diabetes South Africa.
Networks. Networks are groups 
comprising various organizations and 
individuals that converge around 
common issues. Examples include the 
global People’s Health Movement and 
the Right to Food Campaign in India.
Gilson identiﬁ  es four main health 
sector functions for CSOs: service 
provision, social welfare activities, 
support activities, and research and 
advocacy [14].
In relation to research, Jacob 
and Price suggest that investigators, 
especially those in externally funded 
projects with short time frames, should 
identify and work with local CSOs 
in engaging with communities [15]. 
Fruttero and Gauri point out that CSOs 
can “contribute to all different stages of 
the research cycle, namely in advocacy, 
priority setting, capacity building, 
resource mobilization, sharing and 
utilization of research ﬁ  ndings, 
networking, and ethical assessment of 
research being carried out” [10]. 
Sanders et al. have identiﬁ  ed three 
main ways in which the participation of 
CSOs in research, as users or generators 
of research, can be increased. These 
are “inﬂ  uencing commissioning and 
priority-setting [of the research, to 
be relevant to local health needs]; 
becoming involved in the [peer] review 
process and in conducting research; 
and through formal partnerships 
between communities and universities 
that link CSOs with academic 
researchers” [1]. Zafar Ullah et al. 
examined collaborations between the 
government and CSOs in Bangladesh 
in tuberculosis control, and found that 
such partnerships can lead to better 
access and quality of services provided 
[16]. Box 1 gives speciﬁ  c examples of 
how CSOs can play a role in scientiﬁ  c 
and medical research.
There is a widespread perception 
that many CSOs have an anti-science 
agenda. This perception probably 
arose from the fact that the issues 
involving CSOs that attract media 
attention are contentious ones, such 
as environmental degradation (e.g., 
involving Greenpeace), genetically 
modiﬁ  ed organisms (e.g., involving 
GM Watch and Gene Campaign), 
and intellectual property rights, 
particularly in reference to essential 
drugs (e.g., involving the Treatment 
Action Campaign in South Africa). 
Such a perception is misleading, 
as some CSOs play a pivotal role in 
promoting science. For example, 
Bharat Gyan Vigyan Samithi (BGVS or 
the Indian Organization for Learning 
and Science) works in many parts of 
India to make science education widely 
accessible. CSOs are also represented 
on the various advisory boards of the 
International AIDS Vaccine Initiative. 
Widdus identiﬁ  es four challenges 
facing organizations claiming to 
be working in the public interest: 
“representation of intended 
beneﬁ  ciaries, funders and other 
stakeholders; conﬂ  icts of interest, 
which include biases arising from any 
person’s organizational afﬁ  liation 
or strongly held convictions; 
accountability; and transparency” 
[17]. Widdus also cautions that while 
engaging with CSOs is useful, local 
elected governments should not be 
neglected. 
There have been instances where 
well-endowed foreign CSOs have 
provided ﬁ  nancial incentives to 
communities to attend their meetings, 
and this has put poorer, local CSOs at 
•  CSOs can conduct research and 
facilitate technology development. 
An example is the Program for 
Appropriate Technology and Health 
(http: ⁄⁄www.path.org/), which 
conducts frontline research in the 
developing world to develop health 
solutions of relevance to that region, 
independently or in partnership with 
other researchers.
•  CSOs can have a positive impact on 
research agendas by exerting pressure 
on governments and researchers. 
For example, the Treatment Action 
Campaign in South Africa pressured 
the South African government into 
halting its ethically questionable 
research pilot program on nevirapine 
in pregnant mothers with HIV at 
designated research sites, convincing 
them to provide it to pregnant 
mothers with HIV nationwide.
•  CSOs can disrupt scientiﬁ  c endeavors 
and arguably jeopardize science if 
they feel the scientiﬁ  c premise is not 
valid or harmful to the communities 
they serve. For example, activists 
have campaigned against genetically 
modiﬁ  ed organisms, and Act UP Paris 
campaigned to halt the tenofovir trials 
in Cambodia and Cameroon [5].
•  CSOs can play important advocacy 
roles. For example, voluntary health 
organizations sometimes focus on a 
speciﬁ  c disease, such as diabetes, and 
undertake advocacy work with policy 
makers and funders to increase the 
level of funding for researching those 
diseases.
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a disadvantage in getting the attention 
of the local communities [18]. 
Researchers must be careful to ensure 
that the missions of their partner CSOs 
align with the needs of the community 
rather than the donors. There are also 
instances where donors promise one 
thing but do something else on the 
ground [19]; this may result in lack 
of credibility on the part of CSOs and 
any researchers associated with them. 
Furthermore, researchers should be 
aware of potential conﬂ  icts of interest 
when CSOs are motivated primarily 
by a need to sustain donor interest in 
their work rather than responding to 
genuine needs of the communities they 
aim to serve. 
Researchers should strive to 
work with accountable, transparent 
CSOs. A November 2006 article in 
the Washington Post noted how 
pygmy populations in central Africa 
felt exploited by the various CSOs 
collecting funds in their name. “So 
many local NGOs have come to visit 
and promised to build houses,” said a 
Pygmy chief quoted in the article. “But 
so far, nothing.” [20]. Working with 
CSOs in nations where governments 
restrict civil society also entails risks 
for researchers [21]. Collaborating 
with such CSOs may incur unwanted 
government harassment and scrutiny. 
While community engagement in 
developing world research has been 
extensively discussed [22], the role 
of CSOs in increasing community 
engagement in biomedical research 
and enhancing the ultimate adoption 
of the resulting health policies and 
technologies has not been adequately 
explored. 
The Role of CSOs in Biomedical 
Research
We have devised the following 
preliminary taxonomy of six roles 
played by CSOs with an emphasis on 
community engagement in biomedical 
research. 
Community interface. CSOs can play 
a valuable interfacing role between 
researchers and communities on issues 
such as informed consent, negotiating 
ancillary care during trials and post-
trial care/beneﬁ  ts, establishing 
community advisory boards, and 
illuminating sociocultural beliefs 
and practices. CSO members often 
hail from the communities in which 
they work and are generally trusted 
by community members. CSOs have 
intimate knowledge of the health needs 
of communities, and the hierarchical 
nature of relationships within them. 
They can therefore sensitize researchers 
to the community’s particular 
sociocultural practices. CSOs often take 
on the role of cultural interpreters to 
explain the nature of the community 
to researchers and the nature of the 
proposed research to the community in 
a culturally appropriate manner. 
Access point. CSOs can help 
researchers access vulnerable or 
stigmatized communities, such 
as refugee populations or sexual 
minorities, who may be largely 
invisible and inaccessible to an 
external researcher unfamiliar with 
local customs, traditions, or power 
structures. The fact that CSOs are 
nongovernmental and distinguishable 
from governmental power structures 
also makes them more credible and 
trusted in communities that have been 
historically discriminated against by 
the state. The International Committee 
of the Red Cross, Médecins Sans 
Frontières, and Amnesty International 
are examples of CSOs that typically 
have access to vulnerable communities 
who might be unwilling to trust 
or access traditional government 
structures. 
Researcher. Many CSOs are 
primarily research-focused and 
contain experienced biomedical 
and/or social scientists, representing a 
largely untapped resource for outside 
researchers. Such individuals could 
serve as collaborators on investigator-
driven research in areas such as 
epidemiology, social sciences, product 
development, knowledge translation, 
health services, and policy. Examples 
of CSOs in India that are staffed by 
biomedical and social scientists, and 
that have done innovative research 
of relevance to public health in 
developing countries, include SEARCH 
(http: ⁄⁄www.searchgadchiroli.org/) 
with its work on community health 
workers and maternal and neonatal 
health, and SANGATH (http: ⁄⁄www.
sangath.com/sangath/), which focuses 
on mental, reproductive, and sexual 
health.
Touchstone. CSOs may be a valuable 
check to make sure that the research 
being planned and implemented 
is in the best interests of the local 
populations and communities and 
respects their views and rights. 
Advocate. Given their experience 
in working with local policy makers 
and politicians, CSOs can play a 
valuable advocacy role. If research 
ﬁ  ndings indicate that an intervention 
is efﬁ  cacious and sustainable in a 
particular setting, CSOs can pressure 
local health authorities to make the 
intervention available in the public 
health sector in a timely manner and at 
an affordable rate.
Distribution channel. In some cases, 
as in the example of the Bangladesh 
Rural Advancement Committee, CSOs 
can deliver effective interventions 
themselves.
Next Steps 
The full beneﬁ  t of working with 
CSOs in biomedical research in the 
developing world is largely untapped, 
and it needs to be better understood. 
Where appropriate, researchers 
working in the developing world, 
including the GCGH investigators, 
should take advantage of working with 
CSOs. Engaging with CSOs has several 
beneﬁ  ts for researchers, especially 
in approaching and working with 
communities, and for post-research 
adoption of innovative ﬁ  ndings and 
products. CSOs could play a key 
role in fostering understanding of 
how communities currently access 
technology and how they could do so in 
the future. 
Despite the potential beneﬁ  ts of 
working with CSOs for community 
engagement in research, there are few 
empirical studies on best practices for 
collaboration with CSOs, or on the 
steps that research-based CSOs have 
taken in the process of community 
engagement. In the third paper in 
this series, we discussed how our 
project would examine community 
engagement in research through case 
studies [22]. In several of these cases 
we will be focusing on the role of CSOs. 
Empirical research and evaluation of 
best practice models for partnering 
with CSOs in biomedical research 
would be in the best interest of science 
and research in the developing world.  
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